The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of gender in predicting for reduced drug clearance and increased toxicity in non-small cell lung cancer (NSCLC) patients receiving carboplatin and paclitaxel.
V. H. Phan
No relevant relationships to disclose
C. Tan
No relevant relationships to disclose
J. L. Vardy
No relevant relationships to disclose
A. Rittau
No relevant relationships to disclose
H. Xu
No relevant relationships to disclose
F. Zhang
No relevant relationships to disclose
A. J. McLachlan
No relevant relationships to disclose
P. J. Beale
No relevant relationships to disclose
S. J. Clarke
No relevant relationships to disclose